Show simple item record

Meta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1

dc.contributor.authorStewart, S.E.en_US
dc.contributor.authorMayerfeld, C.en_US
dc.contributor.authorArnold, P.D.en_US
dc.contributor.authorCrane, J.R.en_US
dc.contributor.authorO'Dushlaine, C.en_US
dc.contributor.authorFagerness, J.A.en_US
dc.contributor.authorYu, D.en_US
dc.contributor.authorScharf, J.M.en_US
dc.contributor.authorChan, E.en_US
dc.contributor.authorKassam, F.en_US
dc.contributor.authorMoya, P.R.en_US
dc.contributor.authorWendland, J.R.en_US
dc.contributor.authorDelorme, R.en_US
dc.contributor.authorRichter, M.A.en_US
dc.contributor.authorKennedy, J.L.en_US
dc.contributor.authorVeenstra‐vanderweele, J.en_US
dc.contributor.authorSamuels, J.en_US
dc.contributor.authorGreenberg, B.D.en_US
dc.contributor.authorMcCracken, J.T.en_US
dc.contributor.authorKnowles, J.A.en_US
dc.contributor.authorFyer, A.J.en_US
dc.contributor.authorRauch, S.L.en_US
dc.contributor.authorRiddle, M.A.en_US
dc.contributor.authorGrados, M.A.en_US
dc.contributor.authorBienvenu, O.J.en_US
dc.contributor.authorCullen, B.en_US
dc.contributor.authorWang, Y.en_US
dc.contributor.authorShugart, Y.Y.en_US
dc.contributor.authorPiacentini, J.en_US
dc.contributor.authorRasmussen, S.en_US
dc.contributor.authorNestadt, G.en_US
dc.contributor.authorMurphy, D.L.en_US
dc.contributor.authorJenike, M.A.en_US
dc.contributor.authorCook, E.H.en_US
dc.contributor.authorPauls, D.L.en_US
dc.contributor.authorHanna, G.L.en_US
dc.contributor.authorMathews, C.A.en_US
dc.date.accessioned2013-06-18T18:33:34Z
dc.date.available2014-08-01T19:11:35Zen_US
dc.date.issued2013-06en_US
dc.identifier.citationStewart, S.E.; Mayerfeld, C.; Arnold, P.D.; Crane, J.R.; O'Dushlaine, C.; Fagerness, J.A.; Yu, D.; Scharf, J.M.; Chan, E.; Kassam, F.; Moya, P.R.; Wendland, J.R.; Delorme, R.; Richter, M.A.; Kennedy, J.L.; Veenstra‐vanderweele, J. ; Samuels, J.; Greenberg, B.D.; McCracken, J.T.; Knowles, J.A.; Fyer, A.J.; Rauch, S.L.; Riddle, M.A.; Grados, M.A.; Bienvenu, O.J.; Cullen, B.; Wang, Y.; Shugart, Y.Y.; Piacentini, J.; Rasmussen, S.; Nestadt, G.; Murphy, D.L.; Jenike, M.A.; Cook, E.H.; Pauls, D.L.; Hanna, G.L.; Mathews, C.A. (2013). "Metaâ analysis of association between obsessiveâ compulsive disorder and the 3â ² region of neuronal glutamate transporter gene SLC1A1 ." American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162(4): 367-379. <http://hdl.handle.net/2027.42/98412>en_US
dc.identifier.issn1552-4841en_US
dc.identifier.issn1552-485Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98412
dc.description.abstractThe neuronal glutamate transporter gene SLC1A1 is a candidate gene for obsessive‐compulsive disorder (OCD) based on linkage studies and convergent evidence implicating glutamate in OCD etiology. The 3′ end of SLC1A1 is the only genomic region with consistently demonstrated OCD association, especially when analyzing male‐only probands. However, specific allele associations have not been consistently replicated, and recent OCD genome‐wide association and meta‐analysis studies have not incorporated all previously associated SLC1A1 SNPs. To clarify the nature of association between SLC1A1 and OCD, pooled analysis was performed on all available relevant raw study data, comprising a final sample of 815 trios, 306 cases and 634 controls. This revealed weak association between OCD and one of nine tested SLC1A1 polymorphisms (rs301443; uncorrected P  = 0.046; non‐significant corrected P ). Secondary analyses of male‐affecteds only (N = 358 trios and 133 cases) demonstrated modest association between OCD and a different SNP (rs12682807; uncorrected P  = 0.012; non‐significant corrected P ). Findings of this meta‐analysis are consistent with the trend of previous candidate gene studies in psychiatry and do not clarify the putative role of SLC1A1 in OCD pathophysiology. Nonetheless, it may be important to further examine the potential associations demonstrated in this amalgamated sample, especially since the SNPs with modest associations were not included in the more highly powered recent GWAS or in a past meta‐analysis including five SLC1A1 polymorphisms. This study underscores the need for much larger sample sizes in future genetic association studies and suggests that next‐generation sequencing may be beneficial in examining the potential role of rare variants in OCD. © 2013 Wiley Periodicals, Inc.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherMeta‐Analysisen_US
dc.subject.otherSLC1A1en_US
dc.subject.otherGlutamateen_US
dc.subject.otherCandidate Geneen_US
dc.subject.otherOCDen_US
dc.subject.otherObsessive‐Compulsive Disorderen_US
dc.titleMeta‐analysis of association between obsessive‐compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Psychiatry, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationotherDepartment of Child and Adolescent Psychiatry, AP‐HP, Robert Debré Hospital, INSERM U955, Paris, Franceen_US
dc.contributor.affiliationotherInstitut Mondor de Recherche Biomédicale, Psychiatric Genetics, Créteil, Franceen_US
dc.contributor.affiliationotherFoundation Fondamental, French National Science Foundation, Paris, Franceen_US
dc.contributor.affiliationotherDepartment of Psychiatry, Clinic for OCD and Related Disorders, Sunnybrook Health Sciences Center, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherPsychiatric Neurogenetics Lab, Centre for Addiction and Mental Health, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherDepartments of Psychiatry, Pediatrics, and Pharmacology, Vanderbilt Kennedy Center for Research on Human Development and Vanderbilt Brain Institute, Nashville, Tennesseeen_US
dc.contributor.affiliationotherDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Marylanden_US
dc.contributor.affiliationotherDepartment of Psychiatry and Human Behavior, Brown Medical School, Butler Hospital, Providence, Rhode Islanden_US
dc.contributor.affiliationotherDepartment of Psychiatry and Biobehavioral Sciences, School of Medicine, University of California, Los Angeles, Californiaen_US
dc.contributor.affiliationotherDepartment of Psychiatry and The Behavioral Sciences, Zilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, Californiaen_US
dc.contributor.affiliationotherDepartment of Psychiatry, College of Physicians and Surgeons at Columbia University and the New York State Psychiatric Institute, New York, New Yorken_US
dc.contributor.affiliationotherPartners Psychiatry and Mental Health, Belmont, Massachusettsen_US
dc.contributor.affiliationotherDepartment of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, Chicago, Illinoisen_US
dc.contributor.affiliationotherDepartment of Psychiatry, University of California, San Francisco, Californiaen_US
dc.contributor.affiliationotherDepartment of Psychiatry, University of British Columbia, A3‐118, West 28th Avenue, Vancouver, BC, Canada V5Z 4H4.en_US
dc.contributor.affiliationotherMcLean Hospital, Belmont, Massachusettsen_US
dc.contributor.affiliationotherDepartment of Psychiatry, Massachusetts General Hospital, Boston, Massachusettsen_US
dc.contributor.affiliationotherPsychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital, Boston, Massachusettsen_US
dc.contributor.affiliationotherHarvard Medical School, Boston, Massachusettsen_US
dc.contributor.affiliationotherUniversity of British Columbia, Vancouver, British Columbia, Canadaen_US
dc.contributor.affiliationotherBritish Columbia Mental Health and Addictions Research Institute Vancouver, British Columbia, Canadaen_US
dc.contributor.affiliationotherProgram in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherDepartment of Psychiatry, University of Toronto, Toronto, Ontario, Canadaen_US
dc.contributor.affiliationotherProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Boston, Massachusettsen_US
dc.contributor.affiliationotherDepartment of Neurology, Massachusetts General Hospital, Boston, Massachusettsen_US
dc.contributor.affiliationotherDepartment of Neurology, Brigham and Women's Hospital, Boston, Massachusettsen_US
dc.contributor.affiliationotherIntramural Research Program, NIMH, Bethesda, Marylanden_US
dc.contributor.affiliationotherCNS Clinical Biomarker Group, Pharma Research and Early Development, F. Hoffmann‐La Roche Ltd., Basel, Switzerlanden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98412/1/32137_ftp.pdf
dc.identifier.doi10.1002/ajmg.b.32137en_US
dc.identifier.sourceAmerican Journal of Medical Genetics Part B: Neuropsychiatric Geneticsen_US
dc.identifier.citedreferenceAmerican Psychiatric Association. 2000. Diagnostic criteria from DSM‐IV‐TR. Washington, D.C: American Psychiatric Association. Vol. xii, p 370.en_US
dc.identifier.citedreferenceArnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. 2006. Glutamate transporter gene SLC1A1 associated with obsessive‐compulsive disorder. Arch Gen Psychiatry 63 ( 7 ): 760 – 769.en_US
dc.identifier.citedreferenceBacanu SA. 2012. On optimal gene‐based analysis of genome scans. Genet Epidemiol 36 ( 4 ): 333 – 339.en_US
dc.identifier.citedreferenceBailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray‐Blais C, Vandenberg RJ, Bröer S, Rasko JE. 2011. Loss‐of‐function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest 121 ( 1 ): 446 – 453.en_US
dc.identifier.citedreferenceBarrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21 ( 2 ): 263 – 265.en_US
dc.identifier.citedreferenceBogetto F, Venturello S, Albert U, Maina G, Ravizza L. 1999. Gender‐related clinical differences in obsessive‐compulsive disorder. Eur Psychiatry 14 ( 8 ): 434 – 441.en_US
dc.identifier.citedreferenceCavallini MC, Pasquale L, Bellodi L, Smeraldi E. 1999. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 88 ( 1 ): 38 – 43.en_US
dc.identifier.citedreferenceChakrabarty K, Bhattacharyya S, Christopher R, Khanna S. 2005. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 30 ( 9 ): 1735 – 1740.en_US
dc.identifier.citedreferenceCichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, Lehner T, Levinson DF, Moran A, Sklar P, Sullivan PF. 2009. Genomewide association studies: History, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166 ( 5 ): 540 – 556.en_US
dc.identifier.citedreferenceConsortium MDDWGotPG. 2012. A mega‐analysis of genome‐wide association studies for major depressive disorder. Mol Psychiatry Epub ahead of print.en_US
dc.identifier.citedreferenceCoric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. 2005. Riluzole augmentation in treatment‐resistant obsessive‐compulsive disorder: An open‐label trial. Biol Psychiatry 58 ( 5 ): 424 – 428.en_US
dc.identifier.citedreferencede Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. 2008. Practical aspects of imputation‐driven meta‐analysis of genome‐wide association studies. Hum Mol Genet 17 ( R2 ): R122 – R128.en_US
dc.identifier.citedreferenceYucel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C. 2008. Anterior cingulate glutamate–glutamine levels predict symptom severity in women with obsessive‐compulsive disorder. Aust N Z J Psychiatry 42 ( 6 ): 467 – 477.en_US
dc.identifier.citedreferenceHanna GL, Fischer DJ, Chadha KR, Himle JA, Van Etten M. 2005b. Familial and sporadic subtypes of early‐onset obsessive‐compulsive disorder. Biol Psychiatry 57 ( 8 ): 895 – 900.en_US
dc.identifier.citedreferenceHanna GL, Veenstra‐VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH Jr. 2002. Genome‐wide linkage analysis of families with obsessive‐compulsive disorder ascertained through pediatric probands. Am J Med Genet 114 ( 5 ): 541 – 552.en_US
dc.identifier.citedreferenceHanna GL, Veenstra‐Vanderweele J, Cox NJ, Van Etten M, Fischer DJ, Himle JA, Bivens NC, Wu X, Roe CA, Hennessy KA, Dickel DE, Leventhal BL, Cook EH. 2007. Evidence for a susceptibility locus on chromosome 10p15 in early‐onset obsessive‐compulsive disorder. Biol Psychiatry 62 ( 8 ): 856 – 862.en_US
dc.identifier.citedreferenceHemmings SM, Stein DJ. 2006. The current status of association studies in obsessive‐compulsive disorder. Psychiatr Clin North Am 29 ( 2 ): 411 – 444.en_US
dc.identifier.citedreferenceHuang H, Chanda P, Alonso A, Bader JS, Arking DE. 2011. Gene‐based tests of association. PLoS Genet 7 ( 7 ): e1002177.en_US
dc.identifier.citedreferenceInfante‐Rivard C, Mirea L, Bull SB. 2009. Combining case–control and case‐trio data from the same population in genetic association analyses: Overview of approaches and illustration with a candidate gene study. Am J Epidemiol 170 ( 5 ): 657 – 664.en_US
dc.identifier.citedreferenceInouye E. 1965. Similar and dissimilar manifestations of obsessive‐compulsive neuroses in monozygotic twins. Am J Psychiatry 121: 1171 – 1175.en_US
dc.identifier.citedreferenceIvarsson T, Melin K, Wallin L. 2008. Categorical and dimensional aspects of co‐morbidity in obsessive‐compulsive disorder (OCD). Eur Child Adolesc Psychiatry 17 ( 1 ): 20 – 31.en_US
dc.identifier.citedreferenceKanai Y, Hediger MA. 2004. The glutamate/neutral amino acid transporter family SL C1: Molecular, physiological and pharmacological aspects. Pflugers Arch 447 ( 5 ): 469 – 479.en_US
dc.identifier.citedreferenceKarno M, Golding JM, Sorenson SB, Burnam MA. 1988. The epidemiology of obsessive‐compulsive disorder in five US communities. Arch Gen Psychiatry 45 ( 12 ): 1094 – 1099.en_US
dc.identifier.citedreferenceKazeem GR, Farrall M. 2005. Integrating case–control and TDT studies. Ann Hum Genet 69 ( Pt 3 ): 329 – 335.en_US
dc.identifier.citedreferenceKessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005. Prevalence, severity, and comorbidity of 12‐month DSM‐IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62 ( 6 ): 617 – 627.en_US
dc.identifier.citedreferenceKwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, Choi JS, Kim B, Kang DH, Oh S, Park T, Hong KS. 2009. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics‐induced obsessive‐compulsive symptoms. Arch Gen Psychiatry 66 ( 11 ): 1233 – 1241.en_US
dc.identifier.citedreferenceLaird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family‐based tests of association. Genet Epidemiol 19 ( Suppl 1 ): S36 – S42.en_US
dc.identifier.citedreferenceLambert JC, Grenier‐Boley B, Harold D, Zelenika D, Chouraki V, Kamatani Y, Sleegers K, Ikram MA, Hiltunen M, Reitz C, Mateo I, Feulner T, Bullido M, Galimberti D, Concari L, Alvarez V, Sims R, Gerrish A, Chapman J, Deniz‐Naranjo C, Solfrizzi V, Sorbi S, Arosio B, Spalletta G, Siciliano G, Epelbaum J, Hannequin D, Dartigues JF, Tzourio C, Berr C, Schrijvers EM, Rogers R, Tosto G, Pasquier F, Bettens K, Van Cauwenberghe C, Fratiglioni L, Graff C, Delepine M, Ferri R, Reynolds CA, Lannfelt L, Ingelsson M, Prince JA, Chillotti C, Pilotto A, Seripa D, Boland A, Mancuso M, Bossù P, Annoni G, Nacmias B, Bosco P, Panza F, Sanchez‐Garcia F, Del Zompo M, Coto E, Owen M, O'Donovan M, Valdivieso F, Caffara P, Scarpini E, Combarros O, Buée L, Campion D, Soininen H, Breteler M, Riemenschneider M, Van Broeckhoven C, Alpérovitch A, Lathrop M, Trégouët DA, Williams J, Amouyel P. 2012. Genome‐wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry Epub ahead of print.en_US
dc.identifier.citedreferenceLange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. 2004. PBAT: Tools for family‐based association studies. Am J Hum Genet 74 ( 2 ): 367 – 369.en_US
dc.identifier.citedreferenceLangley AK, Lewin AB, Bergman RL, Lee JC, Piacentini J. 2010. Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder. Eur Child Adolesc Psychiatry 19 ( 8 ): 637 – 645.en_US
dc.identifier.citedreferenceLensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. 1996. Obsessive‐compulsive disorder. Familial‐developmental history, symptomatology, comorbidity and course with special reference to gender‐related differences. Br J Psychiatry 169 ( 1 ): 101 – 107.en_US
dc.identifier.citedreferenceWu K, Hanna GL, Rosenberg DR, Arnold PD. 2012. The role of glutamate signaling in the pathogenesis and treatment of obsessive‐compulsive disorder. Pharmacol Biochem Behav 100 ( 4 ): 726 – 735.en_US
dc.identifier.citedreferenceZohar J, Gross‐Isseroff R, Hermesh H, Weizman A. 1999. Is there sexual dimorphism in obsessive‐compulsive disorder ? Neurosci Biobehav Rev 23 ( 6 ): 845 – 849.en_US
dc.identifier.citedreferenceWillour VL, Yao Shugart Y, Samuels J, Grados M, Cullen B, Bienvenu OJ, Wang Y, Liang KY, Valle D, Hoehn‐Saric R, Riddle M, Nestadt G. 2004b. Replication study supports evidence for linkage to 9p24 in obsessive‐compulsive disorder. Am J Hum Genet 75 ( 3 ): 508 – 513.en_US
dc.identifier.citedreferenceWillour VL, Yao Shugart, Samuels Y, Grados J, Cullen M, Bienvenu B, Wang OJ III, Liang Y, Valle KY, Hoehn‐Saric D, Riddle R, Nestadt MG. 2004a. Replication study supports evidence for linkage to 9p24 in obsessive‐compulsive disorder. Am J Hum Genet 75 ( 3 ): 508 – 513.en_US
dc.identifier.citedreferenceWhiteside SP, Port JD, Deacon BJ, Abramowitz JS. 2006. A magnetic resonance spectroscopy investigation of obsessive‐compulsive disorder and anxiety. Psychiatry Res 146 ( 2 ): 137 – 147.en_US
dc.identifier.citedreferenceWendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, Ren‐Patterson RF, Murphy DL. 2009. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive‐compulsive disorder. Arch Gen Psychiatry 66 ( 4 ): 408 – 416.en_US
dc.identifier.citedreferenceWelch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, Feliciano C, Chen M, Adams JP, Luo J, Dudek SM, Weinberg RJ, Calakos N, Wetsel WC, Feng G. 2007. Cortico‐striatal synaptic defects and OCD‐like behaviours in Sapap3‐mutant mice. Nature 448 ( 7156 ): 894 – 900.en_US
dc.identifier.citedreferenceWeissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley‐Browne MA, Rubio‐Stipec M, Wickramaratne PJ, et al. 1994. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry (Suppl 55 ): 5 – 10.en_US
dc.identifier.citedreferenceWang Y, Adamczyk A, Shugart YY, Samuels JF, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen B, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Bienvenu OJ, Riddle M, Liang KY, Valle D, Wang T, Nestadt G. 2010. A screen of SLC1A1 for OCD‐related alleles. Am J Med Genet Part B 153B ( 2 ): 675 – 679.en_US
dc.identifier.citedreferenceWalitza S, Wendland JR, Gruenblatt E, Warnke A, Sontag TA, Tucha O, Lange KW. 2010. Genetics of early‐onset obsessive‐compulsive disorder. Eur Child Adolesc Psychiatry 19 ( 3 ): 227 – 235.en_US
dc.identifier.citedreferenceVeenstra‐VanderWeele J, Xu T, Ruggiero AM, Anderson LR, Jones ST, Himle JA, Kennedy JL, Richter MA, Hanna GL, Arnold PD. 2012. Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive‐compulsive disorder. Psychiatr Genet 22 ( 5 ): 256 – 260.en_US
dc.identifier.citedreferenceVeenstra‐VanderWeele J, Kim SJ, Gonen D, Hanna GL, Leventhal BL, Cook EH Jr. 2001. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early‐onset obsessive‐compulsive disorder. Mol Psychiatry 6 ( 2 ): 160 – 167.en_US
dc.identifier.citedreferencevan Grootheest DS, Cath DC, Beekman AT, Boomsma DI. 2005. Twin studies on obsessive‐compulsive disorder: A review. Twin Res Hum Genet 8 ( 5 ): 450 – 458.en_US
dc.identifier.citedreferenceTukel R, Polat A, Genc A, Bozkurt O, Atli H. 2004. Gender‐related differences among Turkish patients with obsessive‐compulsive disorder. Compr Psychiatry 45 ( 5 ): 362 – 366.en_US
dc.identifier.citedreferenceDickel DE, Veenstra‐VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten‐Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL. 2006. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early‐onset obsessive‐compulsive disorder. Arch Gen Psychiatry 63 ( 7 ): 778 – 785.en_US
dc.identifier.citedreferenceFischer DJ, Himle JA, Hanna GL. 1996. Age and gender effects on obsessive‐compulsive symptoms in children and adults. Depress Anxiety 4 ( 5 ): 237 – 239.en_US
dc.identifier.citedreferenceGeller DA, Biederman J, Griffin S, Jones J, Lefkowitz TR. 1996. Comorbidity of juvenile obsessive‐compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 35 ( 12 ): 1637 – 1646.en_US
dc.identifier.citedreferenceGrados M, Wilcox HC. 2007. Genetics of obsessive‐compulsive disorder: A research update. Expert Rev Neurother 7 ( 8 ): 967 – 980.en_US
dc.identifier.citedreferenceGrant P, Lougee L, Hirschtritt M, Swedo SE. 2007. An open‐label trial of riluzole, a glutamate antagonist, in children with treatment‐resistant obsessive‐compulsive disorder. J Child Adolesc Psychopharmacol 17 ( 6 ): 761 – 767.en_US
dc.identifier.citedreferenceHanna GL, Fingerlin TE, Himle JA, Boehnke M. 2005a. Complex segregation analysis of obsessive‐compulsive disorder in families with pediatric probands. Hum Hered 60 ( 1 ): 1 – 9.en_US
dc.identifier.citedreferenceTrikalinos TA, Salanti G, Zintzaras E, Ioannidis JP. 2008. Meta‐analysis methods. Adv Genet 60: 311 – 334.en_US
dc.identifier.citedreferenceAboujaoude E, Barry JJ, Gamel N. 2009. Memantine augmentation in treatment‐resistant obsessive‐compulsive disorder: An open‐label trial. J Clin Psychopharmacol 29 ( 1 ): 51 – 55.en_US
dc.identifier.citedreferenceTaylor S. 2012. Molecular genetics of obsessive‐compulsive disorder: A comprehensive meta‐analysis of genetic association studies. Mol Psychiatry Epub ahead of print.en_US
dc.identifier.citedreferenceSwedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL. 1989. Cerebral glucose metabolism in childhood‐onset obsessive‐compulsive disorder. Arch Gen Psychiatry 46 ( 6 ): 518 – 523.en_US
dc.identifier.citedreferenceStewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, Illman C, Mayerfeld C, Konkashbaev A, Liu C, Pluzhnikov A, Tikhomirov A, Edlund CK, Rauch SL, Moessner R, Falkai P, Maier W, Ruhrmann S, Grabe HJ, Lennertz L, Wagner M, Bellodi L, Cavallini MC, Richter MA, Cook EH, Kennedy JL, Rosenberg D, Stein DJ, Hemmings SM, Lochner C, Azzam A, Chavira DA, Fournier E, Garrido H, Sheppard B, Umaña P, Murphy DL, Wendland JR, Veenstra‐Vanderweele J, Denys D, Blom R, Deforce D, Van Nieuwerburgh F, Westenberg HG, Walitza S, Egberts K, Renner T, Miguel EC, Cappi C, Hounie AG, Conceição do, Rosário M, Sampaio AS, Vallada H, Nicolini H, Lanzagorta N, Camarena B, Delorme R, Leboyer M, Pato CN, Pato MT, Voyiaziakis E, Heutink P, Cath DC, Posthuma D, Smit JH, Samuels J, Bienvenu OJ, Cullen B, Fyer AJ, Grados MA, Greenberg BD, McCracken JT, Riddle MA, Wang Y, Coric V, Leckman JF, Bloch M, Pittenger C, Eapen V, Black DW, Ophoff RA, Strengman E, Cusi D, Turiel M, Frau F, Macciardi F, Gibbs JR, Cookson MR, Singleton A, Hardy J, Crenshaw AT, Parkin MA, Mirel DB, Conti DV, Purcell S, Nestadt G, Hanna GL, Jenike MA, Knowles JA, Cox N, Pauls DL, Consortium ftNABE, Database ftUBE. 2012. Genome‐wide association study of obsessive‐compulsive disorder. Mol Psychiatry Epub ahead of print.en_US
dc.identifier.citedreferenceStewart SE, Rosario MC, Brown TA, Carter AS, Leckman JF, Sukhodolsky D, Katsovitch L, King R, Geller D, Pauls DL. 2007b. Principal components analysis of obsessive‐compulsive disorder symptoms in children and adolescents. Biol Psychiatry 61 ( 3 ): 285 – 291.en_US
dc.identifier.citedreferenceStewart SE, Rosario MC, Baer L, Carter AS, Brown TA, Scharf JM, Illmann C, Leckman JF, Sukhodolsky D, Katsovich L, Rasmussen S, Goodman W, Delorme R, Leboyer M, Chabane N, Jenike MA, Geller DA, Pauls DL. 2008. Four‐factor structure of obsessive‐compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 47 ( 7 ): 763 – 772.en_US
dc.identifier.citedreferenceStewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, Jenike MA. 2010. A single‐blinded case–control study of memantine in severe obsessive‐compulsive disorder. J Clin Psychopharmacol 30 ( 1 ): 34 – 39.en_US
dc.identifier.citedreferenceStewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL. 2007a. Association of the SLC1A1 glutamate transporter gene and obsessive‐compulsive disorder. Am J Med Genet Part B 144B ( 8 ): 1027 – 1033.en_US
dc.identifier.citedreferenceSmith CP, Weremowicz S, Kanai Y, Stelzner M, Morton CC, Hediger MA. 1994. Assignment of the gene coding for the human high‐affinity glutamate transporter EAAC1 to 9p24: Potential role in dicarboxylic aminoaciduria and neurodegenerative disorders. Genomics 20 ( 2 ): 335 – 336.en_US
dc.identifier.citedreferenceShugart YY, Wang Y, Samuels JF, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen B, Hoehn‐Saric R, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Bienvenu OJ, Riddle MA, Liang KY, Nestadt G. 2009. A family‐based association study of the glutamate transporter gene SLC1A1 in obsessive‐compulsive disorder in 378 families. Am J Med Genet Part B 150B ( 6 ): 886 – 892.en_US
dc.identifier.citedreferenceShugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn‐Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. 2006b. Genomewide linkage scan for obsessive‐compulsive disorder: Evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11 ( 8 ): 763 – 770.en_US
dc.identifier.citedreferenceShugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn‐Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. 2006a. Genomewide linkage scan for obsessive‐compulsive disorder: Evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11 ( 8 ): 763 – 770.en_US
dc.identifier.citedreferenceSaxena S, Rauch SL. 2000. Functional neuroimaging and the neuroanatomy of obsessive‐compulsive disorder. Psychiatr Clin North Am 23 ( 3 ): 563 – 586.en_US
dc.identifier.citedreferenceSamuels J, Wang Y, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Knowles JA, Piacentini J, Cullen B, Bienvenu OJ III, Rasmussen SA, Geller D, Pauls DL, Liang KY, Shugart YY, Nestadt G. 2011. Comprehensive family‐based association study of the glutamate transporter gene SLC1A1 in obsessive‐compulsive disorder. Am J Med Genet Part B 156B ( 4 ): 472 – 477.en_US
dc.identifier.citedreferenceSampaio AS, Fagerness J, Crane J, Leboyer M, Delorme R, Pauls DL, Stewart SE. 2011. Association between polymorphisms in GRIK2 gene and obsessive‐compulsive disorder: A family‐based study. CNS Neurosci Ther 17 ( 3 ): 141 – 147.en_US
dc.identifier.citedreferenceRoss J, Badner J, Garrido H, Sheppard B, Chavira DA, Grados M, Woo JM, Doo P, Umaña P, Fournier E, Murray SS, Mathews CA. 2011. Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD. Hum Genet 130 ( 6 ): 795 – 805.en_US
dc.identifier.citedreferenceRosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ. 2004. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 43 ( 9 ): 1146 – 1153.en_US
dc.identifier.citedreferenceRisch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405 ( 6788 ): 847 – 856.en_US
dc.identifier.citedreferenceRavizza L, Maina G, Bogetto F. 1997. Episodic and chronic obsessive‐compulsive disorder. Depress Anxiety 6 ( 4 ): 154 – 158.en_US
dc.identifier.citedreferenceRauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ. 1994. Regional cerebral blood flow measured during symptom provocation in obsessive‐compulsive disorder using oxygen 15‐labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51 ( 1 ): 62 – 70.en_US
dc.identifier.citedreferencePurcell S, Neale B, Todd‐Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole‐genome association and population‐based linkage analyses. Am J Hum Genet 81 ( 3 ): 559 – 575.en_US
dc.identifier.citedreferencePurcell S, Cherny SS, Sham PC. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 ( 1 ): 149 – 150.en_US
dc.identifier.citedreferencePittenger C, Krystal JH, Coric V. 2006. Glutamate‐modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive‐compulsive disorder. NeuroRx 3 ( 1 ): 69 – 81.en_US
dc.identifier.citedreferencePittenger C, Bloch MH, Williams K. 2011. Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment. Pharmacol Ther 132 ( 3 ): 314 – 332.en_US
dc.identifier.citedreferencePato MT, Pato CN, Pauls DL. 2002. Recent findings in the genetics of OCD. J Clin Psychiatry 63 ( Suppl 6 ): 30 – 33.en_US
dc.identifier.citedreferenceNicolini H, Arnold P, Nestadt G, Lanzagorta N, Kennedy JL. 2009. Overview of genetics and obsessive‐compulsive disorder. Psychiatry Res 170 ( 1 ): 7 – 14.en_US
dc.identifier.citedreferenceNicodemus KK. 2008. Catmap: Case–control and TDT meta‐analysis package. BMC Bioinformatics 9: 130.en_US
dc.identifier.citedreferenceNestadt G, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, LaBuda M, Walkup J, Grados M, Hoehn‐Saric R. 2000b. A family study of obsessive‐compulsive disorder. Arch Gen Psychiatry 57 ( 4 ): 358 – 363.en_US
dc.identifier.citedreferenceNestadt G, Lan T, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, Hoehn‐Saric R, Cullen B, Grados M, Beaty TH, Shugart YY. 2000a. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive‐compulsive disorder and for heterogeneity by sex. Am J Hum Genet 67 ( 6 ): 1611 – 1616.en_US
dc.identifier.citedreferenceNestadt G, Grados M, Samuels JF. 2010. Genetics of obsessive‐compulsive disorder. Psychiatr Clin North Am 33 ( 1 ): 141 – 158.en_US
dc.identifier.citedreferenceMenzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. 2008. Integrating evidence from neuroimaging and neuropsychological studies of obsessive‐compulsive disorder: The orbitofronto‐striatal model revisited. Neurosci Biobehav Rev 32 ( 3 ): 525 – 549.en_US
dc.identifier.citedreferenceMatsunaga H, Kiriike N, Matsui T, Miyata A, Iwasaki Y, Fujimoto K, Kasai S, Kojima M. 2000. Gender differences in social and interpersonal features and personality disorders among Japanese patients with obsessive‐compulsive disorder. Compr Psychiatry 41 ( 4 ): 266 – 272.en_US
dc.identifier.citedreferenceMathews CA, Badner JA, Andresen JM, Sheppard B, Himle JA, Grant JE, Williams KA, Chavira DA, Azzam A, Schwartz M, Reus VI, Kim SW, Cook EH, Hanna GL. 2012. Genome‐wide linkage analysis of obsessive‐compulsive disorder implicates chromosome 1p36. Biol Psychiatry 72 ( 8 ): 629 – 636.en_US
dc.identifier.citedreferenceMataix‐Cols D, Rosario‐Campos MC, Leckman JF. 2005. A multidimensional model of obsessive‐compulsive disorder. Am J Psychiatry 162 ( 2 ): 228 – 238.en_US
dc.identifier.citedreferenceMah AK. 2010. SLITRK5, a protein that links striatal deficits to OCD‐like behaviours in mice. Clin Genet 78 ( 4 ): 350 – 352.en_US
dc.identifier.citedreferenceLin DY, Zeng D. 2010. Meta‐analysis of genome‐wide association studies: No efficiency gain in using individual participant data. Genet Epidemiol 34 ( 1 ): 60 – 66.en_US
dc.identifier.citedreferenceLiang KY, Wang Y, Shugart YY, Grados M, Fyer AJ, Rauch S, Murphy D, McCracken J, Rasmussen S, Cullen B, Hoehn‐Saric R, Greenberg B, Pinto A, Knowles J, Piacentini J, Pauls D, Bienvenu O, Riddle M, Samuels J, Nestadt G. 2008. Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive‐compulsive disorder with compulsive hoarding. Am J Med Genet Part B 147B ( 6 ): 1000 – 1002.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.